EXCERPT
Florida Blue has agreed to provide coverage of the costly but life-saving hepatitis C drug Harvoni to all of its members, ending RICO and ERISA suits and bringing an equivalent of $126 million in relief to proposed class members, according to a settlement that got preliminary approval Tuesday.
“Florida Blue’s agreement to remove the fibrosis restrictions has life-changing, and potentially life-saving implications for thousands of class members and other insureds,” the motion states. “This is an outstanding result.”
Florida Blue was represented by Marcos Daniel Jiménez.
